Electromed Inc (ELMD) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong financial growth, positive analyst ratings, and a bullish technical setup. Despite the lack of recent news or significant trading trends, the positive financial performance and raised price target by analysts make this a solid long-term investment opportunity.
The stock shows a bullish trend with MACD above 0 and positively contracting, RSI in the neutral zone at 55.294, and moving averages aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 25.264, with resistance at 26.159 and support at 24.369.

Raised price target by Roth Capital to $38 from $36, driven by strong performance in the core homecare business. Financials show significant YoY growth in revenue, net income, and EPS.
No significant news or trading trends from hedge funds, insiders, or Congress. Lack of recent AI Stock Picker or SwingMax signals.
In Q2 2026, revenue increased by 16.25% YoY to $18,897,000, net income rose by 40.29% YoY to $2,761,000, EPS grew by 45.45% YoY to 0.32, and gross margin improved to 78.42%, up 0.95% YoY.
Roth Capital maintains a Buy rating and raised the price target to $38 from $36, citing above-expectation results driven by strong performance in the core homecare business.